BioGaia AB Series B

1.09 £
1.71 %

BioGaia AB développe, produit et commercialise des probiotiques destinés à la santé humaine, notamment pour la digestion et la santé buccale.

Performance & Momentum

6 Months 3.93 %
1 Year 3.99 %
3 Years 30.55 %
5 Years 78.43 %

Similar stocks to BioGaia AB Series B

Anantys Community

Be the first to share your analysis on BioGaia AB Series B.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases